zidovudine has been researched along with Necrosis in 13 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (15.38) | 18.7374 |
| 1990's | 6 (46.15) | 18.2507 |
| 2000's | 3 (23.08) | 29.6817 |
| 2010's | 2 (15.38) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Braun, HM; Divi, K; Marrogi, A; Mitchell, JB; Olivero, OA; Ongele, MO; Poirier, MC | 1 |
| Beland, FA; Fang, JL; McGarrity, LJ | 1 |
| Beland, FA; Fang, JL | 1 |
| Aguiar, CV; Braga Neto, MB; Brito, GA; Guerrant, RL; Lima, AA; Maciel, JG; Oliveira, BM; Oriá, RB; Sevilleja, JE; Warren, CA | 1 |
| Lane, RJ; McLean, KA; Moss, J; Woodrow, DF | 1 |
| Duchatelle, V; Durand, F; Hermine, O; Karras, A; Rabian, C; Valla, D; Viard, JP; Zylberberg, H | 1 |
| Aquaro, S; Balestra, E; Caliò, R; Caroleo, MC; Cenci, A; Forbici, F; Ippolito, G; Mastino, A; Mollace, V; Panti, S; Perno, CF; Testi, R | 1 |
| Cornford, ME; Ho, HW; Vinters, HV | 1 |
| Chalmers, AC; Greco, CM; Miller, RG | 1 |
| Armstrong, JA; Hollingsworth, PN; Kakulas, BA; Panegyres, PK; Papadimitriou, JM | 1 |
| Angritt, P; Holland, TT; James, WD; Lupton, GP; Skelton, HG; Smith, KJ | 1 |
| Beschorner, WE; Brant, AM; Green, WR; Guyer, DR; Jabs, DA | 1 |
13 other study(ies) available for zidovudine and Necrosis
| Article | Year |
|---|---|
Selective protection of zidovudine-induced DNA-damage by the antioxidants WR-1065 and tempol.
Topics: Antioxidants; Apoptosis; Cell Line, Tumor; Cell Nucleus; Cell Proliferation; Cell Survival; Chromatin; Chromosomes; Cyclic N-Oxides; Cytochalasin B; DNA Damage; Humans; Mercaptoethylamines; Micronucleus Tests; Mutagens; Necrosis; Radiation-Protective Agents; Spin Labels; Zidovudine | 2014 |
Interference of cell cycle progression by zidovudine and lamivudine in NIH 3T3 cells.
Topics: Animals; Blotting, Western; Bromodeoxyuridine; Cell Cycle; Cell Cycle Proteins; Cell Death; Cell Proliferation; Cell Survival; DNA; Flow Cytometry; Lamivudine; Mice; Necrosis; NIH 3T3 Cells; Zidovudine | 2009 |
Long-term exposure to zidovudine delays cell cycle progression, induces apoptosis, and decreases telomerase activity in human hepatocytes.
Topics: Anti-HIV Agents; Antibodies, Monoclonal; Apoptosis; Blotting, Western; Cell Cycle; Cell Line, Tumor; Cell Survival; Checkpoint Kinase 1; Checkpoint Kinase 2; DNA; Hepatocytes; Humans; Necrosis; Protein Kinases; Protein Serine-Threonine Kinases; Telomerase; Zidovudine | 2009 |
Evaluation of HIV protease and nucleoside reverse transcriptase inhibitors on proliferation, necrosis, apoptosis in intestinal epithelial cells and electrolyte and water transport and epithelial barrier function in mice.
Topics: Animals; Anti-Retroviral Agents; Apoptosis; Body Weight; Cell Membrane Permeability; Cell Proliferation; Didanosine; HIV Protease Inhibitors; Indinavir; Intestinal Absorption; Intestinal Mucosa; Male; Mice; Models, Animal; Necrosis; Nelfinavir; Reverse Transcriptase Inhibitors; Survival Rate; Water-Electrolyte Balance; Zidovudine | 2010 |
Myopathy in HIV infection: the role of zidovudine and the significance of tubuloreticular inclusions.
Topics: Adult; Biopsy; HIV Infections; Humans; Inclusion Bodies; Middle Aged; Mitochondria, Muscle; Mitochondrial Myopathies; Muscles; Muscular Diseases; Myositis; Necrosis; Zidovudine | 1993 |
Severe anoxic hepatic necrosis in an HIV-1-hepatitis C virus-co-infected patient starting antiretroviral triple combination therapy.
Topics: Adult; AIDS-Related Opportunistic Infections; Anti-HIV Agents; Drug Therapy, Combination; Hepatitis C; HIV Protease Inhibitors; HIV-1; Humans; Indinavir; Lamivudine; Male; Necrosis; Red-Cell Aplasia, Pure; Reverse Transcriptase Inhibitors; Zidovudine | 1998 |
Primary macrophages infected by human immunodeficiency virus trigger CD95-mediated apoptosis of uninfected astrocytes.
Topics: Anti-HIV Agents; Apoptosis; Astrocytes; Cell Communication; Cells, Cultured; Fas Ligand Protein; fas Receptor; Gene Products, tat; HIV; HIV Envelope Protein gp120; Homeostasis; Humans; Macrophages; Male; Membrane Glycoproteins; Middle Aged; Necrosis; tat Gene Products, Human Immunodeficiency Virus; Zidovudine | 2000 |
Correlation of neuromuscular pathology in acquired immune deficiency syndrome patients with cytomegalovirus infection and zidovudine treatment.
Topics: Acquired Immunodeficiency Syndrome; Adult; Aged; Cytomegalovirus Infections; Denervation; Female; Ganglia, Spinal; Humans; Immunohistochemistry; Male; Middle Aged; Muscles; Necrosis; Nerve Fibers, Myelinated; Peripheral Nerves; Sarcoma, Kaposi; Sural Nerve; Zidovudine | 1992 |
Prognosis in AZT myopathy.
Topics: Adult; Biopsy; Creatine Kinase; Electromyography; Female; HIV Infections; Humans; Male; Middle Aged; Mitochondria, Muscle; Muscles; Muscular Diseases; Necrosis; Prognosis; Staining and Labeling; Zidovudine | 1991 |
Vesicular changes in the myopathies of AIDS. Ultrastructural observations and their relationship to zidovudine treatment.
Topics: Acquired Immunodeficiency Syndrome; Adult; Biopsy; Cytopathogenic Effect, Viral; Cytoplasm; HIV; Humans; Inclusion Bodies; Male; Microscopy, Electron; Middle Aged; Muscles; Muscular Atrophy; Myofibrils; Necrosis; Sarcoplasmic Reticulum; Zidovudine | 1990 |
Neutrophilic eccrine hidradenitis in HIV-infected patients. Armed Forces Retrovirus Research Group.
Topics: Adult; Eccrine Glands; HIV Infections; Humans; Male; Necrosis; Skin; Sweat Gland Diseases; Zidovudine | 1990 |
Regression of cytomegalovirus retinitis with zidovudine. A clinicopathologic correlation.
Topics: Acquired Immunodeficiency Syndrome; Antigens, Viral; Cytomegalovirus; Cytomegalovirus Infections; DNA, Viral; Humans; Immunoenzyme Techniques; Male; Middle Aged; Necrosis; Nucleic Acid Hybridization; Ophthalmoscopy; Opportunistic Infections; Remission Induction; Retina; Retinitis; Zidovudine | 1989 |
Necrotising myopathy and zidovudine.
Topics: Acquired Immunodeficiency Syndrome; Adult; Female; Humans; Male; Muscular Diseases; Necrosis; Thymidine; Zidovudine | 1988 |